| abstract |
Use of compounds corresponding to the general formula (I) in which R1 represents a hydrogen atom or a C₂-C₄ alkanoyl group, n represents a number from 2 to 4, and R2 represents either a phenyl group optionally carrying from 1 to 3 substituents chosen from halogen atoms and trifluoromethyl, nitro, methylenedioxy, ethylenedioxy, acetyl, hydroxy, mercapto, alkoxy or C₁-C₄ alkylthio, benzyloxy, amino, or acetylamino groups, either a naphthyl group, a thienyl group or a pyridinyl group, for the preparation of medicaments platelet activating factor inhibitors. |